This buyer is looking for a new acquisition in Europe. The company is interested to acquire API synthesis plant or a pharma distribution company in Europe.
A company with more than 3000 employees with global presence and more than 25 years. The group is top 50 private companies in China, which is active in three areas: aluminum, Nanling resorts and pharmaceuticals. The company has 4 subsidiaries with manufacturing facilities in China and has become one of the most innovative and promising pharmaceutical companies in China. The group operate branches in the United Stated, Germany, Japan and Australia.
Contact us to get details about this buyer of API synthesis plant now
The buyer is now looking for a company with an API synthesis plant or a pharma distribution company in Europe.
The goal of the buyer is to acquire a profitable manufacturing pharma company with Revenue in the range of 5 – 50 million Euro.
Feel free to contact us for more information regarding this API synthesis plant firm wanted in Europe or if you know possible interested or suited parties. For more buyers of API synthesis plant, please visit the section pharmaceutical companies wanted. For pharmaceutical manufacturing firm for sale visit the section pharmaceutical companies for sale.
Note: CFIE only works with formal companies. We do get a lot of requests and it is difficult to follow up on all inquiries from visitors to our website. For each company we assess the likelihood of a future transaction. We only get back to you if we see a realistic opportunity to do a future acquisition or business sale. In order to increase your chances of receiving a reply as an individual please explain as much as possible about your personal background strategy and fit with the target. There is also a possibility that your details will be kept on file and we will get back to you once there is an opportunity to do a transaction. CFIE can’t guarantee you will receive an answer to your request.